Search results
Results from the WOW.Com Content Network
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and ...
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...
npj series. The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals.It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine, npj Biofilms and Microbiomes, and npj Schizophrenia.
This article about an academic journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
SLAS Discovery (Advancing the Science of Drug Discovery) is a peer-reviewed scientific journal published by the Society for Laboratory Automation and Screening (SLAS) in partnership with SAGE Publications. The editor-in-chief is Robert M. Campbell, Ph.D. (Eli Lilly and Company). The journal explores how scientists develop and utilize novel ...
MDPI (Multidisciplinary Digital Publishing Institute) is a publisher of open-access scientific journals.It publishes over 390 peer-reviewed, open access journals. [2] [3] MDPI is among the largest publishers in the world in terms of journal article output, [4] [5] and is the largest publisher of open access articles.